Cargando…
2516. Persistence of Anti-HIV Antibodies in HIV-1-infected Patients on Combination Antiretroviral Therapy (cART) with Prolonged Viral Suppression
BACKGROUND: Despite years of cART with sustained HIV-RNA plasma viral load (pVL) < 50 copies/mL, antibodies (Abs) to HIV-1 proteins persist. The reasons for this are unknown but may reflect long-lived B cell responses and/or persistence of antigen. To address which of these may be the case, we co...
Autores principales: | Singh, Kanal, Davis, Ivery, Dewar, Robin L, Imamichi, Hiromi, Lane, H Clifford |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810322/ http://dx.doi.org/10.1093/ofid/ofz360.2194 |
Ejemplares similares
-
Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy
por: Singh, Kanal, et al.
Publicado: (2023) -
Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART
por: Musinguzi, Nicholas, et al.
Publicado: (2021) -
Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)
por: Bischoff, Jenny, et al.
Publicado: (2021) -
Defective HIV-1 proviruses produce viral proteins
por: Imamichi, Hiromi, et al.
Publicado: (2020) -
HIV and cART-Associated Dyslipidemia Among HIV-Infected Children
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2019)